[1]苗艳芳 王玉贤 张声生.痛泻要方对腹泻型肠易激综合征大鼠内脏敏感性及5-羟色胺、5-羟色胺转运体蛋白的影响[J].国际中医中药杂志,2021,43(12):1209-1214.[doi:10.3760/cma.j.cn115398-20210122-00231]
 Miao Yanfang,Wang Yuxian,Zhang Shengsheng.Effects of Tongxie-Yaofang on visceral sensitivity and expression of 5-HT and SERT in IBS-D model rats[J].,2021,43(12):1209-1214.[doi:10.3760/cma.j.cn115398-20210122-00231]
点击复制

痛泻要方对腹泻型肠易激综合征大鼠内脏敏感性及5-羟色胺、5-羟色胺转运体蛋白的影响

参考文献/References:

[1].Chey WD,Kurlander J,Eswaran S. Irritable bowel syndrome:a clinical review[J]. JAMA,2015,313(9):949-958. DOI:10. 1001/jama.2015.0954.
[2].中华中医药学会脾胃病分会. 肠易激综合征中医诊疗专家共识意见(2017)[J]. 中医杂志,2017,58(18):1614-1620. DOI:10.13288/j.11-2166/r.2017.18.024.
[3].肖梦丽,赵迎盼,应佳珂,等. 基于功能性胃肠病的量表疗效评价研究进展[J]. 中国中西医结合消化杂志,2021,29(2): 154-160. DOI:10.3969/j.issn.1671-038X.2021.02.16.
[4].Simrén M ,Tack J. New treatments and therapeutic targets for IBS and other functional bowel disorders[J]. Nat Rev Gastroenterol Hepatol,2018,15(10):589-605. DOI:10.1038/ s41575-018-0034-5.
[5].Wiley JW,Chang L. Functional Bowel Disorders[J]. Gastroenterology,2018,155(1):1-4. DOI:10.1053/j.gastro.2018. 02.014.
[6].陈富丽,窦志芳. 痛泻要方治疗肠易激综合征肝郁脾虚证5-羟色胺作用机制研究[J]. 世界中西医结合杂志,2017, 12(12):1686-1690. DOI :10.13935/j.cnki.sjzx.171214.
[7].杨成,张声生,李晓玲,等. 痛泻要方对内脏高敏感大鼠的影响及机制[J]. 中华中医药杂志,2015,30(12):4268-4271.
[8].李培彩,卢小芳,张声生,等. 腹泻型肠易激综合征大鼠模型的评价研究[J]. 中国中西医结合消化杂志,2016,24(3): 174-177. DOI:10.3969/j.issn.1671-038X.2016.03.04.
[9].Dai YK,Li DY,Zhang YZ,et al. Efficacy and safety of Modified Tongxie Yaofang in diarrhea-predominant irritable bowel syndrome management:A meta-analysis of randomized, positive medicine-controlled trials[J]. PLoS One,2018,13(2): e0192319. DOI:10.1371/journal.pone.0192319.
[10].Bian Z,Wu T,Liu L,et al. Effectiveness of the Chinese herbal formula TongXieYaoFang for irritable bowel syndrome:a systematic review[J]. J Altern Complement Med,2006,12(4): 401-407. DOI:10.1089/acm.2006.12.401.
[11].Pan F,Zhang T,Zhang YH,et al. Effect of Tongxie Yaofang Granule in treating diarrhea-predominate irritable bowel syndrome[J]. Chin J Integr Med,2009,15(3):216-219. DOI:10.1007/s11655-009-0216-7.
[12].Mayer EA,Labus JS,Tillisch K,et al. Towards a systems view of IBS[J]. Nat Rev Gastroenterol Hepatol,2015,12(10): 592-605. DOI:10.1038/nrgastro.2015.121.
[13].Hou Q,Huang Y,Zhu Z,et al. Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways[J]. BMC Complement Altern Med,2019,19(1):337. DOI:10.1186/s12906-019-2749-4.
[14].Bennett G,Talley NJ. Irritable bowel syndrome in the elderly[J]. Best Pract Res Clin Gastroenterol,2002,16(1): 63-76. DOI:10.1053/bega.2001.0266.
[15].Stasi C,Bellini M,Bassotti G,et al. Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome[J]. Tech Coloproctol,2014,18(7):613-621. DOI:10. 1007/s10151-013-1106-8.
[16].Moloney RD,Dinan TG,Cryan JF. Strain-dependent variations in visceral sensitivity:relationship to stress,anxiety and spinal glutamate transporter expression[J]. Genes Brain Behav,2015, 14(4):319-329. DOI:10.1111/gbb.12216.
[17].Wang EM,Li WT,Yan XJ,et al. Vagal afferent-dependent cholecystokinin modulation of visceral pain requires central amygdala NMDA-NR2B receptors in rats[J]. Neurogastroenterol Motil,2015,27(9):1333-1343. DOI:10. 1111/nmo.12633.
[18].Heredia DJ,Gershon MD,Koh SD,et al. Important role of mucosal serotonin in colonic propulsion and peristaltic reflexes:in vitro analyses in mice lacking tryptophan hydroxylase 1[J]. J Physiol,2013,591(23):5939-5957. DOI:10.1113/jphysiol.2013.256230.
[19].Wang LH,Fang XC,Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis[J]. Gut,2004,53(8):1096-1101. DOI:10.1136/gut.2003.021154.
[20].范东芬,奚耕思,梁开丹,等. 五羟色胺转运体的研究进展[J]. 生命科学,2011,23(4):385-389.
[21].常颖. SERT基因多态性及结肠黏膜SERT表达与肠易激综合征关系的研究[D]. 天津:天津医科大学,2012.
[22].陆敏,张伟,姚青,等. 肠康方对肠易激综合征内脏高敏感模型大鼠脑肠轴中5-羟色胺转运体的作用[J]. 世界华人消化杂志,2015,23(8):1231-1237. DOI:10.11569/wcjd.v23.i8.1231.

相似文献/References:

[1]褚衍友.社会支持程度对IBS患者治疗依从性、疗效及生活质量的影响[J].国际中医中药杂志,2009,31(06):542.[doi:10.3760/cma.j.issn.1673-4246.2009.06.034]
 CHU Yan-you.Influence of Social Support on Treatment Compliance, Efficacy and Quality of Life in Patients with Rrritable Bowel Syndrome[J].,2009,31(12):542.[doi:10.3760/cma.j.issn.1673-4246.2009.06.034]
[2]叶涛 陶夏平.乌梅丸用于寒热错杂型腹泻型肠易激综合征的疗效评价[J].国际中医中药杂志,2013,35(08):689.[doi:DOI:10.3760/cma.j.issn.1673-4246.2013.08.006]
 YE Tao,TAO Xia-ping.Curative effect evaluation on 46 cases of cold-heat complex diarrhea type irritable bowel syndrome treated with Wumei pill[J].,2013,35(12):689.[doi:DOI:10.3760/cma.j.issn.1673-4246.2013.08.006]
[3]陈日辉.附子理中汤治疗腹泻型肠易激综合征脾肾阳虚证临床研究[J].国际中医中药杂志,2016,38(04):329.[doi:10.3760/cma.j.issn.1673-4246.2016.04.012]
 Chen Rihui..Clinical study of Fuzi-Lizhong decoction for diarrhea irritable bowel syndrome with Chinese pattern of spleen kidney yang deficiency [J].,2016,38(12):329.[doi:10.3760/cma.j.issn.1673-4246.2016.04.012]
[4]罗海生 杨永光 蔡贤良.针刺联合安肠散穴位贴敷治疗腹泻型肠易激综合征临床研究[J].国际中医中药杂志,2018,40(4):319.[doi:10.3760/cma.j.issn.1673-4246.2018.04.008]
 Luo Haisheng,Yang Yongguang,Cai Xianliang..Observation of curative effect of acupuncture combined with Anchang powder acupoint application in the treatment of irritable bowel syndrome with diarrhea [J].,2018,40(12):319.[doi:10.3760/cma.j.issn.1673-4246.2018.04.008]
[5]崔利娜 刘雷蕾 王韶 孟静岩.中医药治疗肠易激综合征的研究进展[J].国际中医中药杂志,2018,40(7):673.[doi:10.3760/cma.j.issn.1673-4246.2018.07.026]
 Cui Lina*,Liu Leilei,Wang Shao,et al.Research status of traditional Chinese medicine for irritable bowel syndrome [J].,2018,40(12):673.[doi:10.3760/cma.j.issn.1673-4246.2018.07.026]
[6]黄丽 李慢中 李佳.参苓白术散对腹泻型肠易激综合征模型大鼠胃肠激素、消化酶及炎性细胞因子的影响[J].国际中医中药杂志,2018,40(9):836.[doi:10.3760/cma.j.issn.1673-4246.2018.09.012]
 Huang Li*,Li Manzhong,Li Jia..Effect of Shenling-Baizhu powder on gastrointestinal hormone, digestive enzyme and inflammatory factors in diarrhea-predominant irritable bowel syndrome rats [J].,2018,40(12):836.[doi:10.3760/cma.j.issn.1673-4246.2018.09.012]
[7]罗大智 王垂杰.中西医结合治疗腹泻型肠易激综合征研究进展[J].国际中医中药杂志,2019,41(10):1150.[doi:10.3760/cma.j.issn.1673-4246.2019.10.028]
 Luo Dazhi,Wang Chuijie.Research progress of integrated traditional Chinese and western medicine for diarrhea-predominant irritable bowel syndrome[J].,2019,41(12):1150.[doi:10.3760/cma.j.issn.1673-4246.2019.10.028]
[8]马永会.自拟健脾调肝温肾汤治疗腹泻型肠易激综合征临床研究[J].国际中医中药杂志,2019,41(11):1201.[doi:10.3760/cma.j.issn.1673-4246.2019.11.011]
 Ma Yonghui.Clinical study on self-made Jianpi-Tiaogan-Wenshen decoction in the treatment of diarrhea-predominant irritable bowel syndrome [J].,2019,41(12):1201.[doi:10.3760/cma.j.issn.1673-4246.2019.11.011]
[9]刘朝霞 郭秋怡 李贺薇.谢晶日治疗便秘型肠易激综合征肝郁脾虚证经验[J].国际中医中药杂志,2020,42(04):379.[doi:10.3760/cma.j.cn115398-20190420-00144]
 [J].,2020,42(12):379.[doi:10.3760/cma.j.cn115398-20190420-00144]
[10]梁依敏 钟子劭 黄俊敏 黄穗平.基于网络药理学和分子对接探讨四逆散干预肠易激综合征作用机制[J].国际中医中药杂志,2021,43(06):580.[doi:10.3760/cma.j.cn115398-20200610-00129]
 Liang Yimin,Zhong Zishao,Huang Junmin,et al.Mechanism of Sini Powder on treating irritable bowel syndrome based on network pharmacology and molecular docking[J].,2021,43(12):580.[doi:10.3760/cma.j.cn115398-20200610-00129]
[11]孙玉玲 赵登贤.痛泻药方加减治疗腹泻型肠易激综合征83例[J].国际中医中药杂志,2009,31(05):429.[doi:10.3760/cma.j.issn.1673-4246.2009.05.028]
 SUN Yu-ling,ZHAO Deng-xian.Treatment of Irritable Bowel Syndrome with Modified TongXieYaoFang: A 83 Cases Study[J].,2009,31(12):429.[doi:10.3760/cma.j.issn.1673-4246.2009.05.028]

备注/Memo

(收稿日期:2021-01-22)

更新日期/Last Update:

2021-12-16